Laboratory Medicine ›› 2015, Vol. 30 ›› Issue (4): 389-390.DOI: 10.3969/j.issn.1673-8640.2015.04.022
Previous Articles Next Articles
Received:2014-08-05
Online:2015-04-30
Published:2015-05-16
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2015.04.022
| 组别 | 例数 | 年龄(岁) | BMI(kg/m2) | Aβ40(pmol/L) | mAlb(mg/L) |
|---|---|---|---|---|---|
| T2DM下肢大血管病变组 | 37 | 53±7 | 25.6±2.6 | 23.21±8.15*# | 89.43±7.25*# |
| T2DM无下肢大血管病变组 | 43 | 52±5 | 26.2±2.7 | 12.35±9.50* | 34.17±10.21* |
| 正常对照组 | 40 | 49±6 | 24.3±2.5 | 4.38±2.50 | 8.12±7.25 |
| 组别 | 例数 | 年龄(岁) | BMI(kg/m2) | Aβ40(pmol/L) | mAlb(mg/L) |
|---|---|---|---|---|---|
| T2DM下肢大血管病变组 | 37 | 53±7 | 25.6±2.6 | 23.21±8.15*# | 89.43±7.25*# |
| T2DM无下肢大血管病变组 | 43 | 52±5 | 26.2±2.7 | 12.35±9.50* | 34.17±10.21* |
| 正常对照组 | 40 | 49±6 | 24.3±2.5 | 4.38±2.50 | 8.12±7.25 |
| 组别 | 例数 | Aβ40 (pmol/L) | 下肢大血管 病变(%) |
|---|---|---|---|
| 晨尿mAlb阳性组 | 66 | 24.17±8.01* | 34(51.5)* |
| 晨尿mAlb阴性组 | 14 | 13.56±9.72 | 3(21.4) |
| 组别 | 例数 | Aβ40 (pmol/L) | 下肢大血管 病变(%) |
|---|---|---|---|
| 晨尿mAlb阳性组 | 66 | 24.17±8.01* | 34(51.5)* |
| 晨尿mAlb阴性组 | 14 | 13.56±9.72 | 3(21.4) |
| [1] | 李唐瑛,李伟,张旭日,等. 2型糖尿病下肢血管病变的发生率及相关危险因素分析[J].中国热带医学,2008,8(2):254-256. |
| [2] | 许静宜. 糖尿病血管内皮细胞损伤与β淀粉样肽的相关性研究[D].大连:大连医科大学,2012. |
| [3] | 许娜. β淀粉样肽40与糖尿病大血管病变的关系[D].大连:大连医科大学,2008. |
| [4] | 廖新华,冯罡.血清β淀粉样肽40与糖尿病下肢大血管病变[J].中国社区医师(医学专业),2011,13(31):207. |
| [5] | 苏冬月,张韩,李丹丹. 2型糖尿病下肢血管病变患者C反应蛋白与晨尿微量白蛋白的关系[J].河南大学学报:医学版,2010,29(3):213-215. |
| [6] | RING DB,JOHNSON KW, HENRIKSEN EJ, et al.Seletive glycogen synthase kinase 3 inhibitors potentiate insulin activtion of glucose transport and utilization in vitro and in vivo[J].Diabetes,2003,52(3):588-595. |
| [7] | SU Y,Ryder J,LIU B, et al.Lithium, a common drug for bipolar disorder treatment,regulates amyloid-beta precursor protein processing[J].Biochemistry,2004,43(22):6899-6908. |
| [8] | 张晓旸. 2型糖尿病脂联素及尿微量白蛋白与大血管病变的关系[D]. 太原:山西医科大学,2011. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
